α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression
This study investigated the antidepressant potential of α-tocopherol, the most active and abundant form of vitamin E, in the forced swim test (FST) and tail suspension test (TST). The acute oral treatment with α-tocopherol at the doses of 30 and 100 mg/kg reduced the immobility time in the FST and i...
Saved in:
Published in: | Behavioural brain research Vol. 209; no. 2; pp. 249 - 259 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Shannon
Elsevier B.V
19-06-2010
Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | This study investigated the antidepressant potential of α-tocopherol, the most active and abundant form of vitamin E, in the forced swim test (FST) and tail suspension test (TST). The acute oral treatment with α-tocopherol at the doses of 30 and 100
mg/kg reduced the immobility time in the FST and in the TST. A single i.c.v. administration of α-tocopheryl phosphate, a water-soluble analogue of α-tocopherol, also reduced the immobility time in the FST (0.1 and 1
nmol/site) and in the TST (0.1
nmol/site). In addition, the long-term treatment (28 days) with α-tocopherol (10
mg/kg, p.o.) significantly reduced the immobility time in the FST. Moreover, a subeffective dose of α-T (10
mg/kg, p.o.) potentiated the effect of fluoxetine (10
mg/kg, p.o.) in the FST. The long-term treatment with α-T was able to increase the glutathione (GSH) antioxidant defense system, while the acute treatment was not. The long-term treatment with α-tocopherol (10
mg/kg) increased the GSH levels in the hippocampus and in the prefrontal cortex and increased the glutathione peroxidase and glutathione reductase activity in the hippocampus (10
mg/kg) and in the prefrontal cortex (10–100
mg/kg). The long-term treatment with fluoxetine (10
mg/kg, p.o.), a positive control, was also able to increase the GSH levels in the hippocampus, but failed to alter the activity of both enzymes. Besides the specific antidepressant-like effect, long-term, but not the acute treatment with α-T, especially in the doses that produced an antidepressant-like effect (10
mg/kg), improved the antioxidant defenses in the mouse hippocampus and prefrontal cortex, two structures closely implicated in the pathophysiology of depression. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0166-4328 1872-7549 |
DOI: | 10.1016/j.bbr.2010.02.002 |